Opioids Stuck In Pipeline Should Not Wait For REMS, National Pain Foundation Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Products can be folded into new class-wide risk management plan once it is developed, foundation tells FDA public meeting.